Levetiracetam Tablet
Product Images NDC 50405-302

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50405-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sohm, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000mg-30 (1000mg 30)

Levetiracetam Tablets USP 1000 mg oral tablet label from SOHM, Inc. The label shows a package of 30 tablets, includes storage instructions, pharmacist dispensing guidance, and child-resistant packaging information. Manufactured by Stallion Laboratories Pvt. Ltd. in India, the label features the NDC number 50405-303-01 and a barcode.*

FDA Label Image

1000mg-500 (1000mg 500)

Label for Levetiracetam Tablets USP 1000 mg oral tablets by SOHM, Inc. The label includes storage instructions, dosage notes, and distributor and manufacturer information. Package contains 500 tablets with NDC 50405-303-03, and the product is marked Rx only.*

FDA Label Image

1000mg-60 (1000mg 60)

Levetiracetam Tablets USP 1000 mg oral tablets label from SOHM, Inc. The label states the active ingredient as Levetiracetam, USP 1000 mg per tablet, with a package count of 60 tablets. It includes storage instructions, child-resistant packaging information, barcode, manufacturer Stallion Laboratories Pvt. Ltd. in India, and distribution details for SOHM, Inc. in San Diego, California.*

FDA Label Image

Description (1027d3d1 0448 499c A075 62f4377f532e 01)

Chemical structure diagram of Levetiracetam, showing the molecular arrangement including a pyrrolidone ring, ethyl side chain, and amide functional group.*

FDA Label Image

Figure 01 (1027d3d1 0448 499c A075 62f4377f532e 02)

Bar chart comparing the percentage of patients among three groups: Placebo, Levetiracetam Tablet 1000 mg/day, and Levetiracetam Tablet 3000 mg/day. The chart shows increasing patient percentages with higher Levetiracetam doses, with statistically significant differences indicated versus placebo.*

FDA Label Image

Figure 02 (1027d3d1 0448 499c A075 62f4377f532e 03)

A bar chart showing the percentage of patients responding to Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The chart depicts higher response rates in Levetiracetam groups compared to placebo, with statistically significant differences marked by asterisks.*

FDA Label Image

Figure 03 (1027d3d1 0448 499c A075 62f4377f532e 04)

A bar graph comparing the percentage of patients between two groups: Placebo (N=104) with 14.4%, and Levetiracetam 3000 mg/day (N=130) with 39.4%. The graph highlights a statistically significant difference between Levetiracetam and placebo.*

FDA Label Image

Figure 04 (1027d3d1 0448 499c A075 62f4377f532e 05)

Bar chart comparing the percentage of patients between placebo and Levetiracetam Tablet groups. The graph shows approximately 19.6% for placebo (N=97) and 44.6% for Levetiracetam Tablet (N=101), indicating a statistically significant difference versus placebo.*

FDA Label Image

Figure 05 (1027d3d1 0448 499c A075 62f4377f532e 06)

A bar graph comparing the percentage of patients between placebo (19.6%) and Levetiracetam (43.1%) groups, indicating a statistically significant difference favoring Levetiracetam in the measured outcome.*

FDA Label Image

Figure 06 (1027d3d1 0448 499c A075 62f4377f532e 07)

A bar graph comparing the percentage of patients responding to Placebo and Levetiracetam treatment. The vertical axis shows percentage of patients, with placebo at 45.2% and Levetiracetam at 72.2%. The graph notes statistical significance for Levetiracetam versus placebo.*

FDA Label Image

250mg-120 (250mg 120)

Label for Levetiracetam Tablets USP 250 mg, oral tablets distributed by SOHM, Inc. The label indicates the package contains 120 tablets. Storage instructions specify 20-25°C with permitted excursions. Manufactured by Stallion Laboratories Pvt. Ltd. in Gujarat, India. The label includes the NDC 50405-300-02 and a bar code.*

FDA Label Image

250mg-30 (250mg 30s)

Levetiracetam Tablets USP 250 mg tablet bottle label by SOHM, Inc. The label includes the NDC 50405-300-01, dosage strength 250 mg, quantity of 30 tablets, and dispensing instructions. It specifies storage conditions and notes the product is child-resistant. Manufactured by Stallion Laboratories Pvt. Ltd., India.*

FDA Label Image

250mg-500 (250mg 500)

Label for Levetiracetam Tablets USP 250 mg oral tablets. The label includes instructions for pharmacists to dispense in a child-resistant container, storage conditions, and a note to see the package insert for dosage recommendations. The product is distributed by SOHM, Inc. and manufactured by Stallion Laboratories Pvt. Ltd. The package size is 500 tablets. The label features an NDC number 50405-300-03 and a barcode.*

FDA Label Image

500mg-120 (500mg 120)

Levetiracetam Tablets USP 500 mg oral tablets label by SOHM, Inc. The label states each film-coated tablet contains 500 mg of Levetiracetam and indicates a package of 120 tablets. The label includes storage instructions, child-resistant packaging warning, and distributor and manufacturer information. The label features a barcode and mentions the product is Rx only.*

FDA Label Image

500mg-30 (500mg 30)

Label for Levetiracetam Tablets USP 500 mg by SOHM, Inc. This oral tablet contains 500 mg of levetiracetam per film-coated tablet. The label includes storage instructions, child-resistant packaging information, ordering details for 30 tablets, and manufacturing information by Stallion Laboratories Pvt. Ltd. in India.*

FDA Label Image

500mg-500 (500mg 500)

Levetiracetam Tablets USP 500 mg film-coated oral tablets label showing NDC 50405-301-03. The label indicates a 500 count package distributed by SOHM, Inc., San Diego, CA, and manufactured by Stallion Laboratories Pvt. Ltd., Ahmedabad, India. Storage instructions and pharmacist dispensing guidelines are also present along with the SOHM logo.*

FDA Label Image

750mg-120 (750mg 120)

Levetiracetam Tablets USP 750 mg film-coated tablets, oral dosage form. Pack contains 120 tablets. Label shows NDC 50405-302-02 with storage instructions and child-resistant packaging warning. Distributed by SOHM, Inc., San Diego, CA, and manufactured by Stallion Laboratories Pvt. Ltd., Ahmedabad, Gujarat, India. Includes barcode and areas for batch coding details.*

FDA Label Image

750mg-30 (750mg 30)

Levetiracetam Tablets USP 750 mg oral tablet label showing active ingredient strength with storage instructions, child-resistant packaging warning, quantity of 30 tablets, and manufacturer information including SOHM, Inc. and Stallion Laboratories Pvt. Ltd. Barcode and NDC 50405-302-01 are also visible.*

FDA Label Image

750mg-500 (750mg 500)

Label for Levetiracetam Tablets USP 750 mg oral tablets. The label indicates each film-coated tablet contains 750 mg of Levetiracetam and is distributed by SOHM, Inc. It shows storage instructions, pediatric safety warnings, and that the package contains 500 tablets. Manufactured by Stallion Laboratories Pvt. Ltd., India. Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.